MICHAEL SKAGGS: Open Payments
NPI 1861024507 · RIPLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 59 payments from 11 companies in 2025. Trend: 2023 $1,672 · 2024 $852 · 2025 $1,114
Food & beverage: $1,084Education: $31
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $263 |
| ABBVIE INC. | 18 | $249 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $163 |
| Alkermes, Inc. | 8 | $151 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, TRINTELLIX, VIVITROL, Jornay PM, REXULTI, ARISTADA, SPRAVATO.
Industry payments across WV — which companies pay providers there.
